HLTH5613 Module 6 strategy defense example

The Third Quarter at 58 Percent of Target: Defending the Surgery Center Strategy Without Falling for Sunk Costs

Student Name

American College of Education

HLTH5613: Leading and Strategy Development in Healthcare Organizations

Module 6 Assignment

Instructor Name

April 10, 2028

The Disappointing Quarter

Nine months after opening, the surgery center that Cedar Plains Regional Medical Center built with its orthopedic partners performed 210 cases in its third quarter, 58 percent of the 362 cases a quarter needed for steady state. The center lost about $180,000 in the quarter, and the hospital's share of that loss appeared in its financial statements alongside lower outpatient orthopedic revenue at the hospital, which had been expected. At the board meeting, a member who had supported the project asked whether the hospital should begin negotiating an exit before more money was lost.

The question deserves a serious answer, not a defense by reflex. Strategies do fail, and a board that never asks whether to stop is not governing. But one poor quarter in a new facility is also exactly what a normal start-up curve looks like. The task is to tell the difference between a strategy that is late and a strategy that is wrong.

Lagging Results and Leading Indicators

Kaplan and Norton (1992) argued that organizations relying only on financial measures see results too late to act on, and they proposed a balanced scorecard that pairs lagging financial results with leading measures of customers, internal processes and learning. The center's third-quarter loss is a lagging result. The leading indicators tell a more detailed story. Surgeon participation: two of the four planned additional surgeon investors signed in the first year, one later than planned. Case scheduling: the center's booked cases for the fourth quarter already total 298, up from 210 performed in the third. Payer contracts: two of the three largest commercial insurers have signed facility contracts, but the third, covering about 18 percent of the county's commercially insured residents, has not.

The operational measures are strong. Average case time is 22 percent shorter than for comparable cases at the hospital, same-day cancellations are under 2 percent and patient experience scores are in the top decile of the center's benchmarking group. Read together, the indicators suggest that the shortfall is driven by two specific gaps, a surgeon who joined late and a missing insurance contract, rather than by any failure of the center's model.

The Milestones the Board Already Approved

When the board approved the joint venture, it also approved milestones and decision points, and they should govern this discussion rather than the mood of a single meeting. The milestones were: at least two additional surgeon investors within twelve months, contracts with insurers covering at least 80 percent of the county's commercially insured residents within twelve months, 75 percent of target volume by the end of the fourth quarter and break-even by the end of the sixth quarter. The board also agreed in advance that missing two of those milestones at the twelve-month review would trigger a formal reassessment, including the option to restructure or exit.

At nine months, the center has met the surgeon milestone, is behind on the insurer milestone at 82 percent coverage pending the third contract, and is on a trajectory to reach roughly 80 percent of target volume in the fourth quarter based on bookings. None of the review triggers has yet been reached. The milestones were set when no one had a stake in the answer, which is exactly why they deserve more weight than the conversation happening now.

Two Errors to Avoid

Two opposite errors threaten a decision like this one. The first is abandoning a sound strategy too early because of short-term losses; a hospital that exits a partnership nine months in would lose its capital, damage its relationship with the surgeons and hand the orthopedic market to the competitors it set out to meet. The second is persisting in a failing strategy because of what has already been invested. Arkes and Blumer (1985) demonstrated in a series of experiments that people are more likely to continue an endeavor once they have invested money, effort or time in it, even when continuing is not the best choice going forward, and Staw (1976) found that decision makers who felt personally responsible for an initial choice committed more resources to it after negative results. The hospital's executives, who championed the center, are exactly the people most prone to that second error.

The protection against both errors is to judge the decision only on what happens next: the expected future cash flows and strategic value of continuing, compared with the expected value of exiting, ignoring the capital already spent. By that standard, the center's future looks sound if the third insurance contract is signed and scheduled cases continue to rise, and weak if neither happens.

The Recommendation

The recommendation is to continue the strategy through the twelve-month review, with two actions. First, the chief executive and the center's physician chair will meet the third insurer within 30 days to resolve its contract, which the analysis identifies as the single largest constraint on volume. Second, the strategy office will report to the board monthly, rather than quarterly, on the four leading indicators until the twelve-month review. The recommendation would change if the insurer declines to contract within 90 days and fourth-quarter volume falls below 70 percent of target; in that case, the twelve-month review should seriously consider restructuring the center to one operating room or bringing in a larger physician partner.

What the Partners and Staff Need to Hear

A disappointing quarter is also a test of the relationships the engagement plan built. The surgeon investors will have seen the loss in the center's own financial statements and will be watching how the hospital responds; a hospital that talks about exit at nine months signals that it may not be a reliable partner, which could itself cause the volume shortfall to persist. Perioperative staff who moved to the center will hear rumors about its future. The response should therefore be communicated deliberately: the center's physician chair and the hospital's chief executive should meet the investors together to share the leading indicators and the plan for the missing insurer contract, and the center's nurse manager should brief staff on the same facts.

Candor matters in both directions. The investors should hear the milestones and the conditions under which the board would reconsider, so that a later decision to restructure does not come as a surprise. Telling partners the truth about a poor quarter, with a specific plan attached, is more likely to keep them committed than reassurance without detail. The center's success depends on the same relationships the strategy was built to create, and a bad quarter handled openly can strengthen them.

Conclusion

A quarter at 58 percent of target is a poor result and a normal one for a new surgery center. Separating lagging financial results from leading indicators, applying the milestones the board approved before anyone had a stake in the outcome and guarding against both premature exit and escalating commitment lead to a clear answer: the strategy is late, not wrong, and the evidence points to two specific gaps the hospital can close. The defense is credible because it states the conditions under which it would no longer hold.

References

Arkes, H. R., & Blumer, C. (1985). The psychology of sunk cost. Organizational Behavior and Human Decision Processes, 35(1), 124-140. https://doi.org/10.1016/0749-5978(85)90049-4

Kaplan, R. S., & Norton, D. P. (1992). The balanced scorecard: Measures that drive performance. Harvard Business Review, 70(1), 71-79.

Staw, B. M. (1976). Knee-deep in the big muddy: A study of escalating commitment to a chosen course of action. Organizational Behavior and Human Performance, 16(1), 27-44. https://doi.org/10.1016/0030-5073(76)90005-2